| Literature DB >> 35309674 |
Vidhi Jain1, Salman Khan1, Neetha T Ramankutty1, Kirti Vishwakarma1, Akhil D Goel1, Suman Saurabh1, Pankaj Bhardwaj1, Manoj K Gupta1, Sanjeeta Dara2, Ashok Kumar2, Praveen Sharma1, Vijaya Lakshmi Nag1, Sanjeev Misra1.
Abstract
Background: Asymptomatic carriers are responsible for the consistent spread of coronavirus disease 2019 (COVID-19) in the community. The Government of India has deputed house-to-house survey teams to aid in identifying asymptomatic individuals and their susceptible contacts. We selected door-to-door survey teams of a COVID-19 red zone in western India and determined their infectioncontrol practices and anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobin G (IgG) status. Materials andEntities:
Keywords: COVID-19; Community workers; ELISA; India; Kavach ELISA; SARS-CoV-2; field workers; frontline workers; house-to-house survey; serosurvey
Year: 2022 PMID: 35309674 PMCID: PMC8930169 DOI: 10.4103/jfmpc.jfmpc_534_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Participant responses to the structured questionnaire regarding the risk factors predisposing to COVID-19 exposure (between 1st March 1, 2020 and September 1, 2020)
| Responses | No. of participants | Percentage | |
|---|---|---|---|
| Gender | F | 14 | 35.90% |
| M | 25 | 64.10% | |
| Primary occupation of house-to-house survey team members | Doctor | 1 | 2.50% |
| Nurse | 9 | 23.07% | |
| Senior supervisor | 8 | 20.51% | |
| Teacher | 18 | 46.29% | |
| Assistants | 2 | 5.13% | |
| Social worker | 1 | 2.50% | |
| Ever suffered from symptoms related to COVID-19 | Yes | 3 | 7.69% |
| Contact with a lab-confirmed case of COVID-19 | Yes | 8 | 20.51% |
| History of travel outside Jodhpur | Through personal vehicle | 7 | 17.95% |
| Through public transport | 7 | 17.95% | |
| No | 25 | 64.10% | |
| Type of face mask used during house-to-house survey | Cloth mask | 24 | 61.54% |
| N95 mask | 11 | 28.21% | |
| Surgical mask | 4 | 10.25% | |
| Duration of involvement in house-to-house survey work | <2 weeks | 0 | 0 |
| 2-3 weeks | 3 | 7.69 | |
| >3 weeks | 36 | 92.31% | |
| Hydroxychloroquine prophylaxis use (even single dose) | Yes | 4 | 10.25% |
| No | 35 | 89.75% | |
| Anti-SARS-CoV-2 IgG antibody | Positive | 4 | 10.25% |
| Negative | 35 | 92.31% | |
Figure 1Seroprevalence for anti-SARS-CoV-2 antibodies among frontline workers from various countries (May to September 2020)[1213141516]